Horizon Pharma reported 147M in EBIT for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebit Change
Aerie Pharmaceuticals AERI:US $ -18137000 15.51M
ALKERMES ALKS:US -34457000 7.87M
Amgen AMGN:US $ 2176M 324M
AstraZeneca AZN:LN 2.2B 673M
Bristol Myers Squibb BMY:US $ 3197M 9M
Cara Therapeutics CARA:US $ -4472000 23.44M
Eli Lilly And LLY:US $ 1650.5M 919.4M
Horizon Pharma HZNP:US 147M 49.44M
JAZZ PHA JAZZ:US 126.35M 38.8M
Merk MRK:US $ 5711M 652M
Novartis NOVN:VX 3.32B 176M
Pacira Pharmaceuticals PCRX:US $ 13.18M 8.55M
Perrigo Ordinary Shares PRGO:US $ 2.6M 20.5M
Pfizer PFE:US $ 12099M 2104M
Prestige Brands PBH:US $ 87.01M 9.59M
Revance Therapeutics RVNC:US $ -57842000 4.38M
Supernus Pharmaceuticals SUPN:US $ 11.35M 9.38M
Takeda 4502:JP 150.52B 152.13B
Teva Pharmaceutical Industries TEVA:US 734M 55M
Valeant Pharmaceuticals VRX:CN C$ 368.14M 60.14M
Xeris Pharmaceuticals Inc XERS:US $ -18916000 158K
Zoetis ZTS:US $ 737M 57M